`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`Trademark Trial and Appeal Board
`P.O. Box 1451
`Alexandria, VA 22313-1451
`General Contact Number: 571-272-8500
`General Email: TTABInfo@uspto.gov
`
`February 23, 2022
`
`Opposition No. 91266968
`
`CVS Pharmacy, Inc.
`
`v.
`
`Lumeon Ltd
`
`
`
`Kelly Young, Paralegal Specialist:
`
`Applicant’s consented motion, filed February 17, 2022, to suspend this proceeding
`
`for 60 days is granted.
`
`Report Required for Future Motions to Suspend or Extend for Settlement
`
`The Board retains discretion to condition the approval of a consented or stipulated
`
`motion to suspend on the party or parties providing necessary information about the
`
`status of settlement talks, discovery activities, or trial activities, as may be
`
`appropriate. See Trademark Rule 2.117(c); TBMP §§ 510 and 605.02.
`
`Due to the number of suspensions or extensions approved thus far in this
`
`proceeding, the Board imposes a condition on the approval of all future motions to
`
`suspend or extend for settlement. Specifically, to establish good cause for all future
`
`motions to suspend or extend, the parties must include in the motion a status report
`
`setting forth what specific efforts the parties have made towards settlement during
`
`
`
`
`
`Opposition No. 91266968
`
`
`the previous period of suspension or extension. The report must set forth, at a
`
`minimum, 1) all dates on which the parties communicated, and the method of each
`
`communication (e.g. telephone conferences, emails, in-person meetings), 2) the
`
`general nature of each communication, 3) the issues that have been resolved, 4) the
`
`issues that remain to be resolved or that remain for trial, and 5) a proposed timetable
`
`for resolution of the remaining issues. Appropriately designated confidential
`
`information or materials may be filed under seal pursuant to Trademark Rule
`
`2.126(c). See TBMP § 605.02.
`
`Due to this requirement, the parties may no longer use the ESTTA “Consent
`
`Motions” forms to submit motions to extend or suspend dates for settlement. Rather,
`
`the parties must select the “Opposition, Cancellation or Concurrent Use (general
`
`filings)” option, the “Scheduling Motions” option, then the “Motion to Suspend for
`
`Settlement Discussions” form to which the parties may attach the motion they
`
`prepared. The motion must set forth both the required status report and a proposed
`
`trial schedule.1 The requirement to use the general filings ESTTA form is limited to
`
`consent motions based on settlement discussions, and does not prohibit the use of
`
`ESTTA consent forms for other filings.
`
`
`1 When parties stipulate to the rescheduling of a deadline for pretrial disclosures and
`subsequent testimony periods or to the rescheduling of the closing date for discovery and the
`rescheduling of subsequent deadlines for pretrial disclosures and testimony periods, a
`stipulation presented in the form used in a trial order, signed by the parties, or a motion in
`said form signed by one party and including a statement that every other party has agreed
`thereto, shall be submitted to the Board through ESTTA, with the relevant dates set forth
`and an express statement that all parties agree to the new dates. Trademark Rule 2.121(d).
`
`
`
`2
`
`
`
`Opposition No. 91266968
`
`
`Absent the required status report, a motion to suspend or extend may be denied,
`
`even if consented to by the parties. If the Board denies such a motion, dates may
`
`remain as previously set. See TBMP § 509.01(a).
`
`Because the parties are negotiating for a possible settlement of this case,
`
`proceedings are suspended, subject to the right of either party to request resumption
`
`at any time.2 See Trademark Rules 2.117(c) and 2.127(a); and TBMP § 605.02.
`
`If, during the suspension period, either of the parties or their attorneys have a
`
`change of address or email address, the Board should be so informed.3 See Trademark
`
`Rule 2.18(b)(1).
`
`In the event that there is no word from either party concerning the progress of
`
`their negotiations, upon conclusion of the suspension period, proceedings shall
`
`resume without further notice or order from the Board, upon the schedule set
`
`forth below.
`
`An answer must be filed through ESTTA, the Board’s Electronic System for
`
`Trademark Trials and Appeals. See Trademark Rule 2.106(b)(1). Conferencing,
`
`disclosure, discovery, and trial dates are reset as follows:
`
`Proceedings Resume: 4/19/2022
`
`Time to Answer
`
`4/22/2022
`
`
`2 The parties should note that if proceedings are suspended for a lengthy period of time
`pursuant to the filing of several motions to suspend for settlement, the Board retains
`discretion to condition the approval of any future consented or stipulated motion to suspend
`on a party or the parties providing necessary information about the status of settlement talks,
`discovery activities, or trial activities, as may be appropriate. See Trademark Rule 2.117(c).
`
` 3
`
` If the parties are (or during the pendency of this proceeding become) parties to another
`proceeding involving the subject application/registration, the parties must notify the Board
`so the Board can consider whether consolidation or suspension of proceedings is appropriate.
`
`
`
`3
`
`
`
`Opposition No. 91266968
`
`
`Deadline for Discovery Conference
`Discovery Opens
`Initial Disclosures Due
`Expert Disclosures Due
`Discovery Closes
`Plaintiff's Pretrial Disclosures Due
`Plaintiff's 30-day Trial Period Ends
`Defendant's Pretrial Disclosures Due
`Defendant's 30-day Trial Period Ends
`Plaintiff's Rebuttal Disclosures Due
`Plaintiff's 15-day Rebuttal Period Ends
`Plaintiff's Opening Brief Due
`Defendant's Brief Due
`Plaintiff's Reply Brief Due
`Request for Oral Hearing (optional) Due
`
`5/22/2022
`5/22/2022
`6/21/2022
`10/19/2022
`11/18/2022
`1/2/2023
`2/16/2023
`3/3/2023
`4/17/2023
`5/2/2023
`6/1/2023
`7/31/2023
`8/30/2023
`9/14/2023
`9/24/2023
`
`
`Generally, the Federal Rules of Evidence apply to Board trials. Trial testimony is
`
`taken and introduced out of the presence of the Board during the assigned testimony
`
`periods. The parties may stipulate to a wide variety of matters, and many
`
`requirements relevant to the trial phase of Board proceedings are set forth in
`
`Trademark Rules 2.121 through 2.125. These include pretrial disclosures, the
`
`manner and timing of taking testimony, matters in evidence, and the procedures for
`
`submitting and serving testimony and other evidence, including affidavits,
`
`declarations, deposition transcripts and stipulated evidence. Trial briefs shall be
`
`submitted in accordance with Trademark Rules 2.128(a) and (b). Oral argument at
`
`final hearing will be scheduled only upon the timely submission of a separate notice
`
`as allowed by Trademark Rule 2.129(a).
`
`TIPS FOR FILING EVIDENCE, TESTIMONY, OR LARGE DOCUMENTS
`
`The Board requires each submission to meet the following criteria before it will be
`
`considered: 1) pages must be legible and easily read on a computer screen; 2) page
`
`
`
`4
`
`
`
`Opposition No. 91266968
`
`
`orientation should be determined by its ease of viewing relevant text or evidence, for
`
`example, there should be no sideways or upside-down pages; 3) pages must appear in
`
`their proper order; 4) depositions and exhibits must be clearly labeled and numbered
`
`– use separator pages between exhibits and clearly label each exhibit using sequential
`
`letters or numbers; and 5) the entire submission should be text-searchable.
`
`Additionally, submissions must be compliant with Trademark Rules 2.119 and 2.126.
`
`Submissions failing to meet all of the criteria above may require re-filing. Note:
`
`Parties are strongly encouraged to check the entire document before filing.4 The
`
`Board will not extend or reset proceeding schedule dates or other deadlines to allow
`
`time to re-file documents. For more tips and helpful filing information, please visit
`
`the ESTTA help webpage.
`
`
`4 To facilitate accuracy, ESTTA provides thumbnails to view each page before submitting.
`
`
`
`5
`
`



